VICTORIAN EPIGENETICS GROUP (VEG): A COLLABORATION FOR PERSONALISED EPIGENETIC CANCER THERAPY THROUGH PRE-CLINICAL EVALUATION, NOVEL BIOMARKER DEVELOPMENT AND EARLY PHASE CLINICAL TRIALS OF NEW DRUGS.

Grant number: TRP13026 | Funding period: 2014 - 2018

Completed

University of Melbourne Researchers